Astellas Pharmaceuticals
Phase 4 Clinical Trial of Izervay for Geographic Macular Atrophy
Adverum Biotechnology
ARTEMIS trial- To evaluate the efficacy and safety of Ixo-vec (ixoberogene soroparvovec) as a one-time intravitreal (IVT) injection for patients with neovascular (wet) age-related macular degeneration (AMD)
